PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.96%
Both yoy net incomes decline, with MRVL at -43.90%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.40%
Less D&A growth vs. MRVL's 8.43%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-70.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-27.54%
Negative yoy SBC while MRVL is 4.85%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-630.56%
Negative yoy working capital usage while MRVL is 11.58%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-254.29%
Both yoy AR lines negative, with MRVL at -281.82%. Martin Whitman would suspect an overall sector lean approach or softer demand.
148.12%
Some inventory rise while MRVL is negative at -447.48%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-117.81%
Both negative yoy AP, with MRVL at -65.93%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
40.91%
Lower 'other working capital' growth vs. MRVL's 108.26%. David Dodd would see fewer unexpected short-term demands on cash.
100.00%
Well above MRVL's 64.41%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-16.10%
Both yoy CFO lines are negative, with MRVL at -10.44%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-12.31%
Negative yoy CapEx while MRVL is 8.21%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
12.31%
Acquisition growth of 12.31% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-920.08%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-71.82%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-28.23%
Both yoy lines negative, with MRVL at -2006.38%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-252.33%
Both yoy lines negative, with MRVL at -1984.03%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
41.38%
Issuance growth of 41.38% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
98.30%
We have some buyback growth while MRVL is negative at -18.28%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.